14 July 2026
14 July 2026
Regulatory submission for the device was supported by a multinational, prospective, controlled clinical study.
The open-label trial enrolled patients aged between two and 12 years who have a clinical diagnosis of Dravet syndrome.
Cellares will adapt and automate the SBT-77-7101 manufacturing process from Sonoma for use with Cell Shuttle.
The collaboration initially focuses on tuberculosis research in Thailand, where Fosun has identified customer interest.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
